These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Thyrotropin-releasing hormone (TRH) effects on spinal cord neuronal excitability. White SR; Crane GK; Jackson DA Ann N Y Acad Sci; 1989; 553():337-50. PubMed ID: 2497678 [TBL] [Abstract][Full Text] [Related]
49. Analogs of thyrotropin-releasing hormone (TRH): receptor affinities in brains, spinal cords, and pituitaries of different species. Sharif NA; To ZP; Whiting RL Neurochem Res; 1991 Feb; 16(2):95-103. PubMed ID: 1652701 [TBL] [Abstract][Full Text] [Related]
51. Effect of thyrotropin-releasing hormone on Na(+)-K(+)-Adenosine triphosphatase activity following experimental spinal cord trauma. Baykal S; Ceylan S; Usul H; Aktürk F; Değer O Neurol Med Chir (Tokyo); 1996 May; 36(5):296-9. PubMed ID: 8710051 [TBL] [Abstract][Full Text] [Related]
52. Analogs of thyrotropin-releasing hormone: hypotheses relating receptor binding to net excitation of spinal lower motor neurons. Hawkins EF; Beydoun SR; Haun CK; Engel WK Biochem Biophys Res Commun; 1986 Aug; 138(3):1184-90. PubMed ID: 3019335 [TBL] [Abstract][Full Text] [Related]
53. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog. Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872 [TBL] [Abstract][Full Text] [Related]
54. Thyrotropin-releasing hormone: basis and potential for its therapeutic use. Kelly JA Essays Biochem; 1995; 30():133-49. PubMed ID: 8822153 [No Abstract] [Full Text] [Related]
55. The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics. Gary KA; Sevarino KA; Yarbrough GG; Prange AJ; Winokur A J Pharmacol Exp Ther; 2003 May; 305(2):410-6. PubMed ID: 12606661 [TBL] [Abstract][Full Text] [Related]
56. Effect of opiate antagonists on middle cerebral artery occlusion infarct in the rat. Obana WG; Pitts LH; Nishimura MC J Neurosurg; 1988 Jul; 69(1):98-103. PubMed ID: 3132541 [TBL] [Abstract][Full Text] [Related]
57. TRH analog administration increases endogenous TRH levels in the central nervous system. Prasad C; Eloby-Childress S; Iriuchijima T; Wilber JF; Szirtes T; Kisfaludy L Neuroendocrinology; 1989 Feb; 49(2):219-22. PubMed ID: 2542830 [TBL] [Abstract][Full Text] [Related]
58. Hypotension produced by platelet-activating factor is reversed by thyrotropin-releasing hormone. Feuerstein G; Lux WE; Snyder F; Ezra D; Faden AI Circ Shock; 1984; 13(3):255-60. PubMed ID: 6432359 [TBL] [Abstract][Full Text] [Related]
59. Lack of usefulness of DN-1417 for characterization of a CNS receptor for thyrotropin-releasing hormone. Hawkins EF; Wade R; Engel WK J Neurochem; 1987 Jul; 49(1):239-45. PubMed ID: 3035097 [TBL] [Abstract][Full Text] [Related]
60. Effects of MK-771 on the isolated amphibian spinal cord: comparison with thyrotropin-releasing hormone. Yarbrough GG; Singh DK Can J Physiol Pharmacol; 1979 Aug; 57(8):920-2. PubMed ID: 115561 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]